Pfizer signs lease with MIT for research space

Giant drug maker Pfizer Inc. has signed a 10-year lease with the Massachusetts Institute of Technology to locate several research units in the Kendall Square neighborhood of Cambridge, according to the Massachusetts Life Sciences Center.

Pfizer is looking to bring 400 new research jobs to Cambridge, and plans call for the company to station research units specializing in neuroscience and in cardiovascular, metabolic, and endocrine diseases at a new building under development at 610 Main St. South. The lease with MIT is for more than 180,000 square feet of space.

A call to Pfizer was not immediately returned.

In February, Pfizer said that it planned to add about 350 jobs in the Boston area and look for a new site to house a pair of research units it would move here from southeastern Connecticut. At that time, Pfizer had about 2,300 workers at two research labs in Cambridge and a former Wyeth biotechnology plant in Andover. Pfizer said then that it was looking to house its neuroscience and cardiovascular metabolic research operations at a new site, probably in Boston, Cambridge, or Waltham.


The Massachusetts Life Sciences Center is a quasi-public agency of the Commonwealth of Massachusetts. The agency’s mission is to promote life sciences in the Bay State.

Jump To Comments